Initial Evaluation of lncRNA A2M-AS1 Gene Expression in Multiple Sclerosis Patients
lncRNA A2M-AS1, by reducing its expression as an acceptable diagnostic biomarker, can increase the risk of developing MS.
Authors
- Mohammad Rezaei (ORCID: https://orcid.org/0000-0003-3888-5839)
- Shaghayegh Mohammadi
- Mansoureh Azadeh (ORCID: https://orcid.org/0000-0003-2031-4640)
- Tahereh Sadeghiyan
Institutions
- University of Pavia (IT)
- Isfahan Fertility and Infertility Center (IR)
- Agricultural Biotechnology Research Institute of Iran (IR)
Publication Details
- Journal
- Advanced Biomedical Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.4103/abr.abr_422_23
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.86